Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.16%
1,094.54
+1.74
+0.16%
—1,092.801,093.681,094.851,089.86——
SIXC
Communications
SIXC
Communications
SIXC
-0.35%
602.60
-2.14
-0.35%
—604.74604.74604.74601.97——
SIXE
Energy
SIXE
Energy
SIXE
+1.33%
1,230.94
+16.14
+1.33%
—1,214.801,220.811,233.621,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.43%
1,732.01
+7.44
+0.43%
—1,724.571,727.021,732.301,727.02——
SIXM
Financials
SIXM
Financials
SIXM
+0.53%
642.79
+3.36
+0.53%
—639.43641.58644.53641.58——
SIXR
Staples
SIXR
Staples
SIXR
-0.13%
838.06
-1.09
-0.13%
—839.15836.90838.79836.29——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.08%
215.79
+0.17
+0.08%
—215.62215.62216.21215.13——
SIXT
Technology
SIXT
Technology
SIXT
+0.13%
3,183.51
+3.99
+0.13%
—3,179.523,191.503,198.413,178.28——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.26%
934.46
-2.45
-0.26%
—936.91935.42937.17933.26——
SIXV
Health care
SIXV
Health care
SIXV
-0.49%
1,445.67
-7.10
-0.49%
—1,452.771,445.931,446.241,436.78——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.57%
2,351.66
-13.52
-0.57%
—2,365.182,353.642,355.362,348.51——
Q1 2026 earnings • in 1 day
See details
LLY:NYSE
Eli Lilly And Co
$862.00
-1.37%
(-12.00) 1D
Apr 29, 9:50:00 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LLY...
Open
$866.04
High
$869.02
Low
$857.78
Mkt. cap
817.45B
Avg. vol.
2.85M
Volume
118.30K
Dividend
0.80%
Quarterly dividend
$1.73
Ex dividend date
Feb 13, 2026
P/E ratio
37.57
52-wk high
$1,133.95
52-wk low
$623.78
EPS
$22.95
Beta
0.51
Shares outstanding
944.82M
No. of employees
50K
News stories
From sources across the web
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks
Employees50K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorPharmaceutical industry
Websitelilly.com
Next call in 24:08:43
Thu, Apr 30, 10:00 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (6.79 est.)USD
Revenue / Estimate
-/ (17.81B est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
12.73B
15.56B
17.60B
19.29B
Cost of goods sold
2.22B
2.45B
3.01B
3.37B
Cost of revenue
2.22B
2.45B
3.01B
3.37B
Research and development expenses
2.73B
3.34B
3.47B
3.80B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.36B
2.65B
2.63B
3.46B
Operating expense
5.10B
5.98B
6.09B
7.26B
Total operating expenses
7.32B
8.43B
9.10B
10.63B
Operating income
5.41B
7.13B
8.50B
8.66B
Other non operating income
9.00M
-101.00M
-9.10M
181.20M
EBT including unusual items
3.46B
6.78B
7.23B
8.27B
EBT excluding unusual items
5.21B
6.82B
8.21B
8.89B
Income tax expense
696.80M
1.12B
1.65B
1.63B
Effective tax rate
20.16%
16.47%
22.81%
19.70%
Other operating expenses
-
-
-
-
Net income
2.76B
5.66B
5.58B
6.64B
Net profit margin
21.68%
36.38%
31.72%
34.41%
Earnings per share
3.34
6.31
7.02
7.54
Interest and investment income
48.30M
40.00M
65.00M
672.40M
Interest expense
-243.70M
-249.00M
-179.60M
-153.30M
Net interest expenses
-195.40M
-209.00M
-114.60M
519.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.87B
7.60B
8.97B
9.25B
Gain or loss from assets sale
-
-
-
-180.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer